Breast Cancer Treatment: A Review.
Waks AG, Winer EP.
JAMA. 2019 Jan 22;321(3):288-300. doi: 10.1001/jama.2018.19323.
Advances in systemic therapies for triple negative breast cancer.
Leon-Ferre RA, Goetz MP.
BMJ. 2023 May 30;381:e071674. doi: 10.1136/bmj-2022-071674.
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection.
Galant N, Krawczyk P, Monist M, Obara A, Gajek Ł, Grenda A, Nicoś M, Kalinka E, Milanowski J.
Int J Mol Sci. 2024 May 28;25(11):5893. doi: 10.3390/ijms25115893.
Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques.
Czarnywojtek A, Borowska M, Dyrka K, Van Gool S, Sawicka-Gutaj N, Moskal J, Kościński J, Graczyk P, Hałas T, Lewandowska AM, Czepczyński R, Ruchała M.
Pharmacology. 2023;108(5):423-431. doi: 10.1159/000531319. Epub 2023 Jul 17.
Advances in targeted therapy of cholangiocarcinoma.
Li Y, Yu J, Zhang Y, Peng C, Song Y, Liu S.
Ann Med. 2024 Dec;56(1):2310196. doi: 10.1080/07853890.2024.2310196. Epub 2024 Feb 15.
Malignant Melanoma: Beyond the Basics.
Pavri SN, Clune J, Ariyan S, Narayan D.
Plast Reconstr Surg. 2016 Aug;138(2):330e-340e. doi: 10.1097/PRS.0000000000002367.
Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma.
Li G, Wang D, Zhai Y, Pan C, Zhang J, Wang C, Huang R, Yu M, Li Y, Liu X, Liu Y, Wu F, Zhao Z, Hu H, Shi Z, Kahlert UD, Jiang T, Zhang W.
Cell Metab. 2024 Aug 6;36(8):1696-1710.e10. doi: 10.1016/j.cmet.2024.07.011.
Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer.
Chaft JE, Shyr Y, Sepesi B, Forde PM.
J Clin Oncol. 2022 Feb 20;40(6):546-555. doi: 10.1200/JCO.21.01589. Epub 2022 Jan 5.
Medullary thyroid carcinoma.
Pelizzo MR, Mazza EI, Mian C, Merante Boschin I.
Expert Rev Anticancer Ther. 2023 Jul-Dec;23(9):943-957. doi: 10.1080/14737140.2023.2247566. Epub 2023 Aug 30.
Lung cancer.
Maghfoor I, Perry MC.
Ann Saudi Med. 2005 Jan-Feb;25(1):1-12. doi: 10.5144/0256-4947.2005.1.
